These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30816435)

  • 1. lncRNA CASC9 positively regulates CHK1 to promote breast cancer cell proliferation and survival through sponging the miR‑195/497 cluster.
    Shao G; Wang M; Fan X; Zhong L; Wang Z; Zhang P; Ji S
    Int J Oncol; 2019 May; 54(5):1665-1675. PubMed ID: 30816435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
    Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
    Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA (LncRNA) CASC9/microRNA(miR)-590-3p/sine oculis homeobox 1 (SIX1)/NF-κB axis promotes proliferation and migration in breast cancer.
    Chang J; Zhang Y; Ye X; Guo H; Lu K; Liu Q; Guo Y
    Bioengineered; 2021 Dec; 12(1):8709-8723. PubMed ID: 34711117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
    Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer.
    Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X
    J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CASC9 Facilitates Cell Proliferation in Bladder Cancer by Regulating CBX2 Expression.
    Huo W; Tan D; Chen Q
    Nephron; 2020; 144(8):388-399. PubMed ID: 32570259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA CASC9 sponges miR‑758‑3p to promote proliferation and EMT in bladder cancer by upregulating TGF‑β2.
    Zhang Z; Chen F; Zhan H; Chen L; Deng Q; Xiong T; Li Y; Ye J
    Oncol Rep; 2021 Jan; 45(1):265-277. PubMed ID: 33200222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CASC9 activated by STAT3 promotes the invasion of breast cancer and the formation of lymphatic vessels by enhancing H3K27ac-activated SOX4.
    Fan SJ; Cui Y; Li YH; Xu JC; Shen YY; Huang H; Hu ZC
    Kaohsiung J Med Sci; 2022 Sep; 38(9):848-857. PubMed ID: 35860965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CASC9 enhances breast cancer progression by promoting metastasis through the meditation of miR-215/TWIST2 signaling associated with TGF-β expression.
    Zhang J; Wang Q; Quan Z
    Biochem Biophys Res Commun; 2019 Aug; 515(4):644-650. PubMed ID: 31178137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CASC9 Suppressed the Apoptosis of Gastric Cancer Cells through Regulating BMI1.
    Fang J; Chen W; Meng XL
    Pathol Oncol Res; 2020 Jan; 26(1):475-482. PubMed ID: 31642035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.
    Liang Y; Chen X; Wu Y; Li J; Zhang S; Wang K; Guan X; Yang K; Bai Y
    Cell Death Differ; 2018 Nov; 25(11):1980-1995. PubMed ID: 29511340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
    Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLUT-1 participates in the promotion of LncRNA CASC9 in proliferation and metastasis of laryngeal carcinoma cells.
    Xi J; Wang Y; Liu H
    Gene; 2020 Feb; 726():144194. PubMed ID: 31669650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma.
    Zhou J; Xiao H; Yang X; Tian H; Xu Z; Zhong Y; Ma L; Zhang W; Qiao G; Liang J
    Sci Rep; 2018 Jan; 8(1):37. PubMed ID: 29311567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
    Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G
    Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer.
    Pan Z; Mao W; Bao Y; Zhang M; Su X; Xu X
    Cancer Med; 2016 Sep; 5(9):2442-7. PubMed ID: 27431358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA CASC9/miR-519d/STAT3 positive feedback loop facilitate the glioma tumourigenesis.
    Liu H; Li C; Yang J; Sun Y; Zhang S; Yang J; Yang L; Wang Y; Jiao B
    J Cell Mol Med; 2018 Dec; 22(12):6338-6344. PubMed ID: 30270508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.
    Yao J; Xu F; Zhang D; Yi W; Chen X; Chen G; Zhou E
    J Cell Biochem; 2018 Jan; 119(1):680-690. PubMed ID: 28639399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215.
    Kong X; Duan Y; Sang Y; Li Y; Zhang H; Liang Y; Liu Y; Zhang N; Yang Q
    J Cell Physiol; 2019 Jun; 234(6):9105-9117. PubMed ID: 30362551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling.
    Klingenberg M; Groß M; Goyal A; Polycarpou-Schwarz M; Miersch T; Ernst AS; Leupold J; Patil N; Warnken U; Allgayer H; Longerich T; Schirmacher P; Boutros M; Diederichs S
    Hepatology; 2018 Nov; 68(5):1817-1832. PubMed ID: 29790588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.